Medical consumables will be gradually separated from the price items, play the role of market mechanism, and implement centralized procurement and "zero difference rate" sales. Through three to five years of pilot, explore the formation of replicable and scalable medical service price reform experience.
By 2025, the experience of deepening the pilot reform of medical service price will be extended to the whole country, and the medical service price mechanism of classified management, hospital participation, scientific determination and dynamic adjustment will be mature and stereotyped, and the price leverage function will be fully exerted.
The price of medical service is the most concerned, direct and realistic interest of the people. The "Pilot Program" pointed out that at present, there are still some shortcomings in the medical service price formation mechanism, such as weak macro-management, insufficient leverage, and coordination and support to be strengthened.
And the favorable opportunity to implement centralized procurement of pharmaceutical consumables. It should be solved through reform. It is necessary to optimize the allocation of medical service price management authority, improve the rules and procedures for the formulation and adjustment of medical service price, strengthen the capacity building of medical service price management, improve the support system of medical service price management, and make overall plans to promote the compensation mechanism, graded diagnosis and treatment, drug control fees, medical insurance payment and other related reforms in public hospitals, so as to enhance the systematicness, integrity and synergy of the reform and form a comprehensive effect.
The "Pilot Program" clarifies that the National Medical Insurance Bureau will select five pilot cities with relevant departments, directly contact and guide them, and actively, steadily and orderly promote them; Other qualified provinces can also organize cities divided into districts to carry out pilot projects according to local conditions in accordance with the requirements of the pilot program, so as to form replicable and scalable reform experience.
Deepening the reform of medical service price is to further enhance the leading role of medical service price in deepening the reform of medical service supply side by promoting governance innovation, system integration, improving quality and efficiency, and give play to the role of price in promoting fairness, enhancing welfare, encouraging innovation, supporting development and preventing risks. It is not a round of price increase and price reduction, nor is it a ladle of water.
Centralized procurement with quantity aims at "selling pharmaceutical consumables with gold", aiming at purifying the market environment, squeezing out price moisture and reducing the unreasonable burden of the people; The reform of medical service price is aimed at its own shortcomings, aiming at building a more scientific and reasonable price mechanism and giving full play to leverage.
Centralized procurement reduces prices and fees, reducing the burden on ordinary people and winning a window for the reform of medical service prices. However, the two reforms have their own internal logic, which cannot be a simple "seesaw" relationship instead of translating, converting and leaping medical expenses through price reduction and price increase.
From the perspective of the evolution path of the subject, the public highlights public welfare and fully benefits private medical care. The plan points out that the public welfare nature of public hospitals should be adhered to, and the proportion of fees charged by public medical institutions at market-adjusted prices should be strictly controlled, which should not exceed 10% of all medical services. Avoid impacting the dominant position of basic medical services.
The medical services provided by non-public medical institutions shall be subject to the market-regulated price policy and reasonably priced, and shall be included in the scope of medical insurance payment and managed according to the medical insurance agreement. In order to obtain better relative cost performance, under the new price system, high-quality private medical institutions will be more cost-effective than public medical institutions.